newdrugapprovals.org
Gilead’s HCV drug Sovaldi gets Europe OK
Gilead Sciences’ closely-watched hepatitis C drug Sovaldi has been given the green light in Europe. The European Commission has granted marketing authorisation for Sovaldi (sofosbuvir) 400mg …